Senior insider sale
Chief Financial Officer at MONOPAR THERAPEUTICS — senior position signals high conviction
$906.5K
8.18K shares
What this filing means
TSUCHIMOTO KIM R plans to sell 8.18K shares of MONOPAR THERAPEUTICS valued at approximately $906.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/26/2026ACC: 0001950047-26-008721
Officer· Chief Financial Officer
Since Aug 2018
8.18K
Shares to sell
$906.5K
Approx. market value
8.18K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
8/26/2026
8.18KTotal acquired8.18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/26/2026 | Exercise of Stock Options Cash | 8.18K | — |
| Total | 8.18K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
8.18K
Market value
$906.5K
8/26/2026
Total
Units
8.18K
Value
$906.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/26/2026 | 8.18K | $906.5K | NASDAQ | Planned |
| Total | 8.18K | $906.5K | ||